IL1B and metabolic dysfunction-associated steatotic liver disease: Recent studies also reported that PBMCs of NAFLD patients are more sensitive to gut-derived pathogen-associated molecular patterns (PAMPs) and release higher amounts of proinflammatory cytokines (IL-1β and IL-6) upon PAMP exposure than PBMCs derived from controls [38,39].